Evidence map›Paper›PMID 40004048›Full record

ReviewInternational journal of molecular sciences2025

Dual Doping in Precious Metal Oxides: Accelerating Acidic Oxygen Evolution Reaction.

Guoxin Ma, Fei Wang, Rui Jin, Bingrong Guo, Haohao Huo, Yulong Dai, Zhe Liu, Jia Liu, Siwei Li

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Guoxin MaInstitute of Industrial Catalysis, School of Chemical Engineering and Technology, Xi'an Jiaotong University, Xi'an 710049, China.ORCID 0009-0007-2355-7599
Fei WangInstitute of Industrial Catalysis, School of Chemical Engineering and Technology, Xi'an Jiaotong University, Xi'an 710049, China.
Rui JinInstitute of Industrial Catalysis, School of Chemical Engineering and Technology, Xi'an Jiaotong University, Xi'an 710049, China.
Bingrong GuoInstitute of Industrial Catalysis, School of Chemical Engineering and Technology, Xi'an Jiaotong University, Xi'an 710049, China.
Haohao HuoInstitute of Industrial Catalysis, School of Chemical Engineering and Technology, Xi'an Jiaotong University, Xi'an 710049, China.
Yulong DaiInstitute of Industrial Catalysis, School of Chemical Engineering and Technology, Xi'an Jiaotong University, Xi'an 710049, China.
Zhe LiuInstitute of Neuroscience, Translational Medicine Institute, Xi'an Jiaotong University Health Science Center, Xi'an 710061, China.
Jia LiuInstrumental Analysis Center, Xi'an Jiaotong University, Xi'an 710049, China.
Siwei LiInstitute of Industrial Catalysis, School of Chemical Engineering and Technology, Xi'an Jiaotong University, Xi'an 710049, China.

Funding

Innovation Capability Support Program of Shaanxi NO. 2023-CX-TD-26Sanqin Talent Introduction Plan of Shaanxi 2023SYJ13The Natural Science Foundation of China 22209129
6 · The paper itself

Abstract

Developing a highly active and stable catalyst for acidic oxygen evolution reactions (OERs), the key half-reaction for proton exchange membrane water electrolysis, has been one of the most cutting-edge topics in electrocatalysis. A dual-doping strategy optimizes the catalyst electronic environment, modifies the coordination environment, generates vacancies, and introduces strain effects through the synergistic effect of two elements to achieve high catalytic performance. In this review, we summarize the progress of dual doping in RuO

Indexed as

MetalsOxidesOxygenCatalysisOxidation-ReductionMetalsOxidesOxygenacidic oxygen evolution reactiondual dopingelectrocatalysisprecious metal oxides

Identifiers

PMID40004048
PMCPMC11855536

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.